Members Capital Advisors Inc’s Quest Diagnostics DGX Stock Holding History

Members Capital Advisors Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,140	Closed	-$205K	–	12
2025 Q2	$205K	Hold	1,140	–	–	0.24%	19
2025 Q1	$193K	Hold	1,140	–	–	0.22%	21
2024 Q4	$172K	Hold	1,140	–	–	0.15%	23
2024 Q3	$177K	Hold	1,140	–	–	0.2%	25
2024 Q2	$156K	Hold	1,140	–	–	0.18%	25
2024 Q1	$152K	Hold	1,140	–	–	0.43%	24
2023 Q4	$157K	Sell	1,140 -9,008	-89%	-$1.18M	0.45%	24
2023 Q3	$1.24M	Hold	10,148	–	–	1.54%	25
2023 Q2	$1.43M	Sell	10,148 -3,045	-23%	-$420K	1.46%	29
2023 Q1	$1.87M	Hold	13,193	–	–	1.35%	29
2022 Q4	$2.06M	Hold	13,193	–	–	1.48%	24
2022 Q3	$1.62M	Hold	13,193	–	–	1.28%	36
2022 Q2	$1.75M	Hold	13,193	–	–	1.27%	36
2022 Q1	$1.81M	Hold	13,193	–	–	1.16%	37
2021 Q4	$2.28M	Buy	13,193 +1,581	+14%	+$241K	1.17%	22
2021 Q3	$1.69M	Hold	11,612	–	–	0.92%	35
2021 Q2	$1.53M	Hold	11,612	–	–	0.95%	45
2021 Q1	$1.49M	Buy	+11,612	New	+$1.43M	1.14%	36

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Members Capital Advisors Inc's DGX Position: Q3 2025 in Review

Members Capital Advisors Inc sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 1,140 shares — an estimated $205K sold.

Members Capital Advisors Inc first reported a position in DGX in Q1 2021 and held it in 18 quarters. The position peaked at $2.28M in Q4 2021. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Members Capital Advisors Inc reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Members Capital Advisors Inc sold 1,140 Quest Diagnostics shares in Q3 2025, an estimated $205K.
Members Capital Advisors Inc first reported a position in Quest Diagnostics in Q1 2021 and held it in 18 quarters.
Members Capital Advisors Inc's Quest Diagnostics position peaked at $2.28M in Q4 2021.
1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Members Capital Advisors Inc's 13F filing for Q3 2025, filed 24 Oct 2025.